Page last updated: 2024-09-04

cyc 202 and exenatide

cyc 202 has been researched along with exenatide in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (exenatide)	Trials (exenatide)	Recent Studies (post-2010) (exenatide)
979	7	393	2,806	383	2,016

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galons, H; Kitani, K; Matsui, H; Meijer, L; Nishiki, T; Oguma, S; Ohmori, I; Tomizawa, K	1

Other Studies

1 other study(ies) available for cyc 202 and exenatide

Article	Year
A Cdk5 inhibitor enhances the induction of insulin secretion by exendin-4 both in vitro and in vivo. The journal of physiological sciences : JPS, 2007, Volume: 57, Issue:4 Topics: Age Factors; Animals; Blood Glucose; Cell Line; Cyclin-Dependent Kinase 5; Dose-Response Relationship, Drug; Exenatide; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Peptides; Protein Kinase Inhibitors; Purines; Roscovitine; Venoms	2007

Article

Year

A Cdk5 inhibitor enhances the induction of insulin secretion by exendin-4 both in vitro and in vivo.

The journal of physiological sciences : JPS, 2007, Volume: 57, Issue:4

Topics: Age Factors; Animals; Blood Glucose; Cell Line; Cyclin-Dependent Kinase 5; Dose-Response Relationship, Drug; Exenatide; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Peptides; Protein Kinase Inhibitors; Purines; Roscovitine; Venoms

2007